Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.

MLA

Bhatt, Ankeet S., et al. “Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.” JAMA Cardiology, vol. 8, no. 11, Nov. 2023, pp. 1041–48. EBSCOhost, https://doi.org/10.1001/jamacardio.2023.3216.

APA

Bhatt, A. S., Vaduganathan, M., Claggett, B. L., Fonarow, G. C., Packer, M., Pfeffer, M. A., Shah, S. J., Shen, X., Cristino, J., McMurray, J. J. V., Solomon, S. D., & Gaziano, T. A. (2023). Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management. JAMA Cardiology, 8(11), 1041–1048. https://doi.org/10.1001/jamacardio.2023.3216

Chicago

Bhatt, Ankeet S, Muthiah Vaduganathan, Brian L Claggett, Gregg C Fonarow, Milton Packer, Marc A Pfeffer, Sanjiv J Shah, et al. 2023. “Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.” JAMA Cardiology 8 (11): 1041–48. doi:10.1001/jamacardio.2023.3216.